alexa
Reach Us +1 218 451 2974
Using Branched Chain Amino Acids As A Novel Therapeutic For Brain Injury | 2610
ISSN: 2155-9562

Journal of Neurology & Neurophysiology
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Using branched chain amino acids as a novel therapeutic for brain injury

International Conference and Exhibition on Neurology & Therapeutics

Jeffrey T Cole

ScientificTracks Abstracts: J Neurol Neurophysiol

DOI: 10.4172/2155-9562.S1.08

Abstract
Traumatic brain injury (TBI) is a leading cause of death and disability in the United States, with an annual average of over 50,000 fatalities each year. Mortality rates appear to be declining, although this is more likely attributable to improved safety measures and increasingly rapid responses rather than the development of effective therapies. Branched chain amino acids (BCAAs) may prove to be a key component of any treatment that is clinically effective. Following a TBI, BCAAs appear to be the only amino acids whose concentration in the injured brain regions is significantly altered following the injury. In vitro application of BCAAs to hippocampal slices restored electrophysiological parameters to normal, while providing these same amino acids via the drinking water restored cognitive performance 7 days after the injury. However, the mechanisms of these effects have not been determined. Recently, this laboratory has determined a likely mechanism for this improvement by investigating the effects of BCAA treatment on calcium homeostasis after brain injury. BCAAs appear to ameliorate calcium dystasis after an injury. Regulation of calcium will allow the BCAAs to have exquisite control over neurotransmitter trafficking and synaptic release, which in turn regulates electrophysiological function and thus cognitive abilities. Further, BCAAs will ameliorate impaired bioenergetic function in both mitochondria and cytosol by altering the activity of both calcium-dependent and ?independent enzyme activity. Results thus far suggest tremendous promise for the use of BCAAs as a therapy for traumatic brain injury.
Biography
Dr. Jeffrey Cole completed his Ph.D from North Carolina State University before completing postdoctoral studies at Wake Forest University School of Medicine and the Children?s Hospital of Philadelphia. He is currently an assistant professor in the Neurology Department at Uniformed Services University. where he leads a team investigating treatments for Traumatic Brain Injury.
Relevant Topics
Top